RxDoctor Payments Data

Clancy Cone

Internal Medicine · Missoula, MTNPI 1366421620

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Novo Nordisk at 50.8% of the total.

$192in general payments, 2019–2025

Across 7 payments — averaging $27.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$97
  • Pfizer$31
  • Astellas Pharma US Inc$23
  • Merck$23
  • AstraZeneca$17
$2,575,233in research payments, 2019–2025

Across 1,030 payments — averaging $2500.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$1.7M
  • Eli Lilly$172K
  • GSK$139K
  • AstraZeneca$129K
  • AbbVie$113K
  • Radius Health, Inc.$76K
  • plus $225K from 7 others

What the payments were for

  • Food & beverage$192100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk1$97
Pfizer2$31
Astellas Pharma US Inc1$23
Merck2$23
AstraZeneca1$17

How this compares

$192 in reported general payments places this provider in the 75th percentile of 244 internal medicine providers in Montana.

See all internal medicine providers in Montana

Other internal medicine in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →